Three-drug therapy with autologous stem cell transplant improves survival in multiple myeloma: NEJM Dr. Kamal Kant Kohli15 Jun 2022 2:30 PM GMTResearchers have found in a new study appearing in New England journal of Medicine that among adults with multiple myeloma, RVD plus ASCT was...
PSA prostate cancer screening found more beneficial than previous estimates, especially for blacks Dr. Kamal Kant Kohli13 Jun 2022 2:30 PM GMTNew research led by investigators from Weill Cornell Medicine, Fred Hutchinson Cancer Center, University Hospitals Cleveland and Case Western Reserve...
Kite gets USFDA nod for new CAR T-cell therapy site in Maryland Ruchika Sharma20 April 2022 7:42 AM GMTSanta Monica: Kite, a Gilead Company has announced the U.S. Food and Drug Administration (USFDA) has approved commercial production at the company's...
Understanding Lymphoma (Blood Cancer) Dr Meet Kumar8 Oct 2021 9:52 AM GMTIn this video, Hematologist Dr. Meet Kumar explains the disease and its management
New approach to reducing Breast Cancer Incidence and Mortality Hina Zahid1 Oct 2021 3:30 AM GMTA commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer...
COVID-19 vaccines exhibits limited protection in blood cancer patients: Study Dr Satabdi Saha24 April 2021 2:45 AM GMTIn a recent development, research has highlighted that mRNA COVID-19 vaccines may not fully protect people with the blood cancers, chronic...
Diabetes linked to higher risk of blood cancers: Study Medha Baranwal16 March 2021 6:15 AM GMTCanada: Diabetes patients are at a higher risk of haematological malignancies and mortality, finds a recent study in the journal Diabetologia....
AstraZeneca to launch cancer drug Acalabrutinib under brand name Calquence Ruchika Sharma16 Oct 2020 5:55 AM GMTNew Delhi: Drug firm AstraZeneca Pharma India on Thursday said it will launch its Acalabrutinib 100 mg capsules, used for treatment of various types...
Cadila pharma unveils biosimilar Rituximab under brand name Ritucad Ruchika Sharma30 July 2020 7:31 AM GMTRitucad is used in the treatment of Non-Hodgkin's lymphoma( a type of blood-related cancer)
Researchers attempt new treatment approach for blood cancer Hina Zahid25 Jun 2020 3:01 AM GMT(Boston)--In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific...
Clinical trial shows promising new treatment for rare Lymphoma Hina Zahid1 Jun 2020 12:30 PM GMTLymphoma is a type of blood cancer that develops from lymphocytes (a type of white blood cell). It has many subtypes. A rare subtype, called...
Treating COVID-19 in a patient with multiple myeloma: Case study Dr. Kamal Kant Kohli3 April 2020 4:18 PM GMTA case study published in Blood Advances has found that Aocilizumab was effective in addressing COVID-19 symptoms for people with blood cancers
